Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pleuroperitoneal shunt for malignant pleural effusions].

S Sadahiro, O Tsumura, K Kubouchi

    Nihon Gan Chiryo Gakkai Shi
    |January 20, 1989
    PubMed
    Summary

    This study explored a novel technique for malignant pleural effusion by directing fluid into the abdominal cavity. While effective in reducing effusion and improving patient status, it carries a risk of tumor cell spread.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    p-wave superconductivity in iron-based superconductors.

    Scientific reports·2019
    Same author

    In situ heating TEM observations on carbide formation and α-Fe recrystallization in twinned martensite.

    Scientific reports·2018
    Same author

    Lath formation mechanisms and twinning as lath martensite substructures in an ultra low-carbon iron alloy.

    Scientific reports·2018
    Same author

    Reply to the Letter to the editor 'Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus Sorafenib for advanced hepatocellular carcinoma: randomized phase II trial' by Fornaro et al.

    Annals of oncology : official journal of the European Society for Medical Oncology·2017
    Same author

    Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2016
    Same author

    Randomized phase III trial of treatment duration for oral uracil and tegafur plus leucovorin as adjuvant chemotherapy for patients with stage IIB/III colon cancer: final results of JFMC33-0502.

    Annals of oncology : official journal of the European Society for Medical Oncology·2015

    Area of Science:

    • Oncology
    • Thoracic Surgery
    • Palliative Care

    Context:

    • Malignant pleural effusion is a common complication of advanced lung and breast cancer.
    • Existing treatments for malignant pleural effusion can be invasive and may not always provide adequate symptom relief.
    • The need for effective and minimally invasive palliative procedures for malignant pleural effusion is significant.

    Purpose:

    • To evaluate the safety and efficacy of a technique involving the manual compression of a pleuroperitoneal shunt tube to introduce malignant pleural effusion into the abdominal cavity.
    • To assess the impact of this procedure on effusion retention and patient performance status.
    • To investigate the potential risk of peritoneal tumor dissemination associated with this intervention.

    Summary:

    Related Experiment Videos

  • Seven patients with malignant pleural effusion (4 lung cancer, 3 breast cancer) underwent the pleuroperitoneal shunt procedure under local anesthesia.
  • The technique resulted in marked reduction of pleural effusion without serious complications.
  • Patients with better preoperative performance status (2 or 3) showed feasibility and potential for early discharge, unlike those with performance status 4.
  • Impact:

    • This procedure offers a potentially useful therapeutic option for hospitalized patients with malignant pleural effusion, improving symptom control.
    • A significant risk of iatrogenic peritoneal tumor dissemination was observed in one autopsy case, necessitating careful patient selection.
    • The decision to apply this technique should be individualized, considering the patient's overall prognosis and the risk-benefit profile.